Opinion|Videos|July 29, 2024

Biosimilars in the Commercial Sector

Dr. Cannon discusses payers and PBMs making decisions about biosimilars in the commercial sector.

Video content above is prompted by the following:

  • How are payers and PBMs making decisions about biosimilars in the commercial sector?

a. What key factors are considered for formulary decisions in the commercial sector?

b. Discussion points: What makes the commercial sector unique, employer/payer payment models.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo